Non Sustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy and New Ultrasonic Derived Parameters

Journal of the American Society of Echocardiography

Volumn 23, Issue 6, 2010, Pages 581-590

  Di Salvo, Giovanni ^a   Pacileo, Giuseppe ^a   Limongelli, Giuseppe ^a   Baldini, Luca ^a   Rea, Alessandra ^a   Verrengia, Marina ^a   D'Andrea, Antonello ^a   Russo, Maria Giovanna ^a   Calabrò, Raffaele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Echocardiography; Hypertrophic cardiomyopathy; Ventricular tachycardia

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DISOPYRAMIDE; SOTALOL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY SURFACE; DEFIBRILLATOR; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART RIGHT VENTRICLE OVERLOAD; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; SYNCOPE; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; VALSALVA MANEUVER;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; YOUNG ADULT;

EID: 77952498694     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2010.02.013     Document Type: Article

References (41)

1. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
2. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
3. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., et al. American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy. Eur Heart J 24 (2003) 1965-1991
4. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36 (2000) 2212-2218
5. Cecchi F., Olivotto I., Gistri R., Lorenzoni R., Chiriatti G., and Camici P.G. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349 (2003) 1027-1035
6. Maron B.J. Sudden death in young athletes. N Engl J Med 349 (2003) 1064-1075
7. Elliott P., and McKenna W.J. Hypertrophic cardiomyopathy. Lancet 363 (2004) 1881-1891
8. Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., and Mueller F.O. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276 (1996) 199-204
9. Tanaka M., Fujiwara H., Onodera T., Wu D.J., Hamashima Y., and Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 55 (1986) 575-581
10. Factor S.M., Butany J., Sole M.J., Wigle E.D., Williams W.C., and Rojkind M. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 17 (1991) 1343-1351
11. Oka K., Tsujino T., Nakao S., Lee-Kawabata M., Ezumi A., Masai M., et al. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy. J Cardiol 52 (2008) 146-153
12. Shirani J., Pick R., Roberts W.C., and Maron B.J. Morphology and significance of left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 35 (2000) 36-44
13. Varnava A.M., Elliott P.M., Baboonian C., Davison F., Davies M.J., and McKenna W.J. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104 (2001) 1380-1384
14. Schuster P., Matre K., and Faerestrand S. Assessment of regional timing of left ventricular systolic longitudinal movement by Doppler tissue synchronization imaging in structurally normal hearts. Eur J Echocardiogr 6 (2005) 336-343
15. Yu C.M., Zhang Q., Fung J.W., Chan H.C., Chan Y.S., and Yip G.W. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol 45 (2005) 677-684
16. Gorcsan III J., Kanzaki H., Bazaz R., Dohi K., and Schwartzman D. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol 93 (2004) 1178-1181
17. Sutherland G.R., Di Salvo G., Claus P., D'hooge J., and Bijnens B. Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial function. J Am Soc Echocardiogr 17 (2004) 788-802
18. D'hooge J., Heimdal A., Jamal F., Kukulski T., Bijnens B., Rademakers F., et al. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 1 (2000) 154-170
19. Ganame J., Mertens L., Eidem B.W., Claus P., D'hooge J., Havemann L.M., et al. Regional myocardial deformation in children with hypertrophic cardiomyopathy: morphological and clinical correlations. Eur Heart J 28 (2007) 2886-2894
20. Perk G., Tunick P.A., and Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography-from technical considerations to clinical applications. J Am Soc Echocardiogr 20 (2007) 234-243
21. Amundsen B.H., Helle-Valle T., Edvardsen T., Torp H., Crosby J., Lyseggen E., et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 47 (2006) 789-793
22. Rasmussen V.G., Poulsen S.H., Dupont E., Ostergaard K., Safikhany G., and Egeblad H. Ergotamine-derived dopamine agonists and left ventricular function in Parkinson patients: systolic and diastolic function studied by conventional echocardiography, tissue Doppler imaging, and two-dimensional speckle tracking. Eur J Echocardiogr 9 (2008) 803-808
23. Kang S.J., Lim H.S., Choi B.J., Choi S.Y., Yoon M.H., Hwang G.S., et al. Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension. J Am Soc Echocardiogr 21 (2008) 907-911
24. Popović Z.B., Benejam C., Bian J., Mal N., Drinko J., Lee K., et al. Speckle-tracking echocardiography correctly identifies segmental left ventricular dysfunction induced by scarring in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol 292 (2007) H2809-H2816
25. Serri K., Reant P., Lafitte M., Berhouet M., Le Bouffos V., Roudaut R., et al. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1175-1181
26. Park S.H., Shub C., Nobrega T.P., Bailey K.R., and Seward J.B. Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography. J Am Soc Echocardiogr 9 (1996) 119-128
27. Nishimura R.A., and Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta stone. J Am Coll Cardiol 30 (1997) 8-18
28. Adabag A.S., Casey S.A., Kuskowski M.A., Zenovich A.G., and Maron B.J. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 45 (2005) 697-704
29. Maron B.J. Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy. Heart 89 (2003) 977-978
30. Adabag A.S., Maron B.J., Appelbaum E., Harrigan C.J., Buros J.L., Gibson C.M., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1369-1374
31. D'Andrea A., Caso P., Severino S., Cuomo S., Capozzi G., Calabrò P., et al. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. Eur Heart J 27 (2006) 1311-1318
32. Garot J., Bluemke D.A., Osman N.F., Rochitte C.E., McVeigh E.R., Zerhouni E.A., et al. Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI. Circulation 101 (2000) 981-988
33. Moore C.C., McVeigh E.R., and Zerhouni E.A. Quantitative tagged magnetic resonance imaging of the normal human left ventricle. Top Magn Reson Imaging 11 (2000) 359-371
34. Castillo E., Lima J.A., and Bluemke D.A. Regional myocardial function: advances in MR imaging and analysis. Radiographics 23 (2003) S127-S140
35. Popović Z.B., Kwon D.H., Mishra M., Buakhamsri A., Greenberg N.L., Thamilarasan M., et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr 21 (2008) 1299-1305
36. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
37. Payá E., Marín F., González J., Gimeno J.R., Feliu E., Romero A., et al. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail 14 (2008) 414-419
38. Kapoun A.M., Liang F., O'Young G., Damm D.L., Quon D., White R.T., et al. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94 (2004) 453-461
39. Roldán V., Marín F., Gimeno J.R., Ruiz-Espejo F., González J., Feliu E., et al. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Am Heart J 156 (2008) 85-91
40. De Boeck B.W., Meine M., Leenders G.E., Teske A.J., van Wessel H., Kirkels J.H., et al. Practical and conceptual limitations of tissue Doppler imaging to predict reverse remodelling in cardiac resynchronisation therapy. Eur J Heart Fail 10 (2008) 281-290
41. Hawkins N.M., Petrie M.C., Burgess M.I., and McMurray J.J. Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony. J Am Coll Cardiol 53 (2009) 1944-1959